Category Archives: Gene Therapy

Paying for gene therapy are annuities the next big thing Paying for gene therapy are annuities the next big thing. By: Reuters-BBC-Aljazeera … Continue reading →

Cystic Fibrosis Gene Therapy A short animation to briefly explain the research being conducted at the Gene Therapy Department of the Adelaide Women's and Children's Hospital. Donations can be made at http://www.cure4cf.org/ By: WCH Gene Therapy … Continue reading →

Home Books Author Jeanne Ryan discusses Charisma and gene therapy Author Jeanne Ryan talks with Hypable about her book Charisma and whether or not she would take her fictional drug if given the chance. Charisma follows the story of Aislyn, a painfully shy junior in high school who suffers from social anxiety. Speaking up in class and trying to have fun with her friends at a party are well outside her comfort zone. She finds out about a new underground gene therapy treatment in the form of a drug called Charisma. Aislyns personality completely changes, and suddenly shes exactly the person she wanted to be all along. But theres one problem. The therapy appears to be contagious and deadly. Worse yet, the doctor who gave her and a select number of other patients the drug suddenly disappears. Read our review. Tell us 5 random facts about yourself. Two of my brothers have the same name, kind of by accident. Just after my mom gave birth to her sixth kid in less than seven years, the nurse asked the name of her baby. Thinking the nurse meant the baby at home, my sleep-deprived mom gave her his name, and it ended … Continue reading →

Walking barefoot on sand "felt like walking on glass" for Keith Wenckowski, who has lived with type-one diabetes for more than two decades. One of the participants in a new Northwestern Medicine study who suffered from painful diabetic neuropathy (PDN), Wenckowski finally found relief from the constant foot pain that required him to wear shoes at all times, even to the beach. The study found that those with PDN who received two low dose rounds of a non-viral gene therapy called VM202 had significant improvement of their pain that lasted for months. "I can now go to a beach and walk on the sand without feeling like I am walking on glass," Wenckowski said. The results of this phase two, double-blind, placebo-controlled study will be published March 5 in the journal Annals of Clinical and Translation Neurology. Right now there is no treatment for this disease of the peripheral nerves that affects 20 to 25 percent of diabetics. Patients with the most extreme form of the disease feel intense pain with a slight graze or touch. The pain can interfere with daily activities, sleep, mood and can diminish quality of life. "Those who received the therapy reported more than a … Continue reading →

S75RS04 Gene Therapy Science Technology ITV Schools circa 1986. By: Lammas Science … Continue reading →

The Gene Therapy Plan: Taking Control of Your Genetic Destiny with Diet and Lifestyle By Mitchell L. Gaynor MD (Author), Mehmet C. Oz M.D. (Foreword) http://genechanger.com/gene-therapy-plan-taking-control-genetic-destiny-diet-lifestyle/ From ... By: Mitchell Gaynor M.D. … Continue reading →

Advances in gene therapy and the deepening understanding of cancer will see the oft-fatal disease becoming treatable in two decades, said cancer researcher Inder M. Varma. Cancer mutations are being exposed cancer is in retreat through a combination of surgery, radiation, chemotherapy, molecular and genetic therapy, cancer will become a chronic disease rather than a terminal one, said Dr. Verma, a professor in Laboratory of Genetics at the Salk Institute for Biological Studies, at the Infosys Science Foundation Lecture at the National Centre for Biological Sciences here on Wednesday. His optimism was elaborated through an intriguing cat-and-mouse game that played out for over five years of research into the Glioblastomas multiforme (GBM), a lethal form of brain cancer that kills the patient within 14 months. Understanding GBM was critical as relapse, even after surgery or treatment, was certainty, said Prof. Verma. The researchers at the Salk Institute developed a novel genetic technique to switch on genes in around five cells of a mouse brain to make them into cancer cells. The cells grew to all parts of the brain, but more importantly, they started to exhibit stem cell characteristics, said Dr. Verma. Unlike the normal cell, a stem cell can … Continue reading →

DUBLIN, Mar. 03, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/gxqhg9/gene_therapy) has announced the addition of Jain PharmaBiotech's new report "Gene Therapy - Technologies, Markets and Companies" to their offering. Gene therapy technologies are described in detail including viral vectors, nonviral vectors and cell therapy with genetically modified vectors. Gene therapy is an excellent method of drug delivery and various routes of administration as well as targeted gene therapy are described. There is an introduction to technologies for gene suppression as well as molecular diagnostics to detect and monitor gene expression. Clinical applications of gene therapy are extensive and cover most systems and their disorders. Full chapters are devoted to genetic syndromes, cancer, cardiovascular diseases, neurological disorders and viral infections with emphasis on AIDS. Applications of gene therapy in veterinary medicine, particularly for treating cats and dogs, are included. Research and development is in progress in both the academic and the industrial sectors. The National Institutes of Health (NIH) of the US is playing an important part. As of 2014, over 2050 clinical trials have been completed, are ongoing or have been approved worldwide.A breakdown of these trials is shown according to the geographical areas and applications. Since the death of Jesse … Continue reading →

DUBLIN, Mar. 03, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/rcv4lq/gene_therapy) has announced the addition of the "Gene Therapy Market, 2015 - 2025" report to their offering. The "Gene Therapy Market, 2015-2025" report provides an extensive study on the marketed and pipeline gene therapies. A lot of research has been carried out in this field for over a decade but there are only five approved therapies (four available in Asian markets; one approved in the EU). There are many promising therapies which are currently being developed worldwide; the approach is likely to result in several commercial success stories in the foreseen future. The report covers various aspects, such as key players, marketed gene therapy products, products in clinical / pre-clinical research, associated ethical issues, likely future developments and upcoming opportunities for a variety of stakeholders. Several disorders that arise inside the body are a result of either a direct genetic aberration or a dysfunctional/non-functional protein. The attempt to use nucleic acids to correct or delete the genes causing a particular disease is known as gene therapy. Although gene therapy has not contributed significantly to the global pharmaceutical market yet, it is anticipated to grow at a fast pace over the next decade. … Continue reading →

Carlsbad, CA (PRWEB) February 28, 2015 A study out of the University of Oxford has developed a promising new gene therapy procedure for the treatment of a hereditary ocular condition that leads to progressive blindness in patients. Authored by Dr. Robert MacLaren, professor of ophthalmology at the University of Oxford and published in the Lancet Medical Journal on January 16, 2014, the study treated six patients suffering from choroideremia, a rare genetic disorder that mostly affects men and leads to the degeneration of the choroid and retina, eventually causing blindness. Night blindness and loss of peripheral vision are the most common symptoms of choroideremia. For the study, researchers injected the subjects with healthy genetic material in an attempt to repair the damaged portions of the patients own gene, halting the onset of blindness. Developing technologies and gene therapy are the future of ophthalmology, said Carlsbad LASIK surgeon Dr. Michael Tracy. In the past, there was little that could be done for certain patients facing blindness due to genetic and degenerative conditions. Gene therapy can lead to treatments that can stop the onset of blindness in certain patients before its too late. For the Oxford study, researchers used virus particles to … Continue reading →